Nonalcoholic fatty liver disease therapeutic (WestGene Biopharma)

非酒精性脂肪肝 (成都威斯津生物医药科技有限公司)

Report date: 2025/01/20 11:55:20
NME

Base Information

Drug NameNonalcoholic fatty liver disease therapeutic (WestGene Biopharma)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionProtein replacements
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Westgene Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Westgene Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A